The modulation by neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors.
Neurosteroids have been reported to modulate learning and memory processes in aged animals and in pharmacological models of amnesia. We report here the effects of dehydroepiandrosterone sulfate (DHEAS), pregnenolone sulfate (PREGS), and progesterone (PROG) on the learning impairment induced in mice by the muscarinic acetylcholine receptor antagonist, scopolamine. Spatial working memory was examined using the spontaneous alternation behavior in a Y-maze and long-term memory using place learning in a rectangular water-maze adapted for mice. Both DHEAS and PREGS (5-20 mg/kg, s.c.) prevented dose-dependently and significantly the scopolamine (2 mg/kg, s.c.)-induced alternation deficits. PROG (2-20 mg/kg, s.c.) failed to affect the scopolamine-induced deficits, but blocked, at 20 mg/kg, the beneficial effects induced by DHEAS or PREGS. In the water-maze, DHEAS (20 mg/kg) attenuated significantly the scopolamine-induced deficits, as observed during the acquisition sessions or the retention test. PROG (2, 20 mg/kg) did not affect the control or scopolamine-treated group performances, but blocked the ameliorating effect of DHEAS. Furthermore, in both tests, the selective sigma1 (sigma1) receptor antagonist NE-100 (1 mg/kg, i.p.) failed to affect the behaviors showed by the control or scopolamine-treated groups, but it blocked the ameliorating effects induced by DHEAS or PREGS. These results confirm the modulating role of neurosteroids in learning and memory processes and demonstrate that their modulation of the cholinergic systems involves an interaction with sigma1 receptors.
Unité 336 de l'Institut National de la Santé et de la Recherche Médicale, Développement, Plasticité et Vieillissement du Système Nerveux, ENSCM, 8, rue de l'Ecole Normale, 34296 Montpellier Cedex 5, France.
A
A
Urani
A
A
Privat
T
T
Maurice
D000818:Animals; D000840:Anisoles / Q000494:pharmacology; D019314:Dehydroepiandrosterone Sulfate / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D007859:Learning Disabilities / Q000139:chemically induced*; D008297:Male; D018782:Maze Learning / Q000187:drug effects; D051379:Mice; D018727:Muscarinic Antagonists; D011284:Pregnenolone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011374:Progesterone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D011437:Propylamines / Q000494:pharmacology; D017480:Receptors, sigma / Q000037:antagonists & inhibitors / Q000187:drug effects* / Q000502:physiology; D012601:Scopolamine; D013550:Swimming
D000840:Anisoles; D018727:Muscarinic Antagonists; D011437:Propylamines; D017480:Receptors, sigma; C018370:pregnenolone sulfate; C083832:N,N-dipropyl-2-(4-methoxy-3-(2-phenylethoxy)phenyl)ethylamine monohydrochloride; D011374:Progesterone; D019314:Dehydroepiandrosterone Sulfate; D011284:Pregnenolone; D012601:Scopolamine